Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OSPEMIFENE vs OXAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OSPEMIFENE vs OXAZEPAM: Safety Overview

Metric OSPEMIFENE OXAZEPAM
Total FAERS Reports 2,047 12,440
Deaths Reported 2 2,965
Death Rate 0.1% 23.8%
Hospitalizations 60 6,242
Average Patient Age 61.7 yrs 57.3 yrs
% Female Patients 99.8% 58.3%
FDA Approval Date Feb 13, 2024 Approved Prior to Jan 1, 1982
Manufacturer Duchesnay USA, Inc. Aphena Pharma Solutions - Tennessee, LLC
Route ORAL ORAL
Marketing Status Prescription Discontinued